Replimune (REPL) Shares Outstanding (Entity) (2017 - 2026)
Replimune (REPL) recorded Shares Outstanding (Entity) of 83.98 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 7.9% from 77.81 million a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Replimune reported Shares Outstanding (Entity) of 82.72 million, up 7.3% from FY2025.
- Annual Shares Outstanding (Entity) has increased for nine straight fiscal years, with a five-year compound annual growth rate of 12.2% (FY2021 to FY2026).
- Across earlier fiscal years, Shares Outstanding (Entity) came in at 77.09 million in FY2025 (+25.5%), 61.42 million in FY2024 (+8.4%), 56.68 million in FY2023 (+19.7%) and 47.34 million in FY2022 (+1.7%).
- The fiscal Q1 2027 figure is the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q1 2018.
- On a year-over-year basis, Shares Outstanding (Entity) has increased for 33 consecutive quarters, with growth averaging 14.2% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 1.7% (fiscal Q4 2022) and 25.5% (fiscal Q4 2025) over the last five years.
- Per Business Quant, the preceding three fiscal quarters came in at 82.72 million (Q4 2026), 79.63 million (Q3 2026) and 78.4 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 83.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.98 Mn |
| Mar 31, 2026 | 82.72 Mn |
| Dec 31, 2025 | 79.63 Mn |
| Sep 30, 2025 | 78.40 Mn |
| Jun 30, 2025 | 77.81 Mn |
| Mar 31, 2025 | 77.09 Mn |
| Dec 31, 2024 | 77.01 Mn |
| Sep 30, 2024 | 68.39 Mn |
| Jun 30, 2024 | 68.31 Mn |
| Mar 31, 2024 | 61.42 Mn |
| Dec 31, 2023 | 61.39 Mn |
| Sep 30, 2023 | 59.06 Mn |
| Jun 30, 2023 | 58.98 Mn |
| Mar 31, 2023 | 56.68 Mn |
| Dec 31, 2022 | 56.63 Mn |
| Sep 30, 2022 | 49.74 Mn |
| Jun 30, 2022 | 49.30 Mn |
| Mar 31, 2022 | 47.34 Mn |
| Dec 31, 2021 | 47.21 Mn |
| Sep 30, 2021 | 46.86 Mn |
API Access
Replimune Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();